FLGT – Fulgent Genetics, Inc.
Fulgent Genetics, Inc.FLGT
$17.10Name : Fulgent Genetics, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $523,034,304.00
EPSttm : -5.52
Fulgent Genetics, Inc.
$17.10
2.29%$0.4Float Short %
4.85
Margin Of Safety %
Put/Call OI Ratio
0.14
EPS Next Q Diff
-0.08
EPS Last/This Y
5.47
EPS This/Next Y
-0.3
Price
17.1
Target Price
26.33
Analyst Recom
2.67
Performance Q
-14.93
Relative Volume
0.68
Beta
1.41
Ticker: FLGT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | FLGT | 18.78 | 0.43 | 0.00 | 2153 |
| 2024-12-20 | FLGT | 18.35 | 0.42 | 0.93 | 2183 |
| 2024-12-23 | FLGT | 18.61 | 0.46 | 0.19 | 1529 |
| 2024-12-24 | FLGT | 18.51 | 0.46 | 0.00 | 1552 |
| 2024-12-26 | FLGT | 18.69 | 0.46 | 0.12 | 1557 |
| 2024-12-27 | FLGT | 18.34 | 0.46 | 1.00 | 1563 |
| 2024-12-30 | FLGT | 18.44 | 0.47 | 0.00 | 1582 |
| 2024-12-31 | FLGT | 18.49 | 0.13 | 0.00 | 4608 |
| 2025-01-02 | FLGT | 18.41 | 0.13 | 0.05 | 4626 |
| 2025-01-03 | FLGT | 18.73 | 0.12 | 0.75 | 4680 |
| 2025-01-06 | FLGT | 18.8 | 0.13 | 0.00 | 4689 |
| 2025-01-07 | FLGT | 18.95 | 0.12 | 0.05 | 4711 |
| 2025-01-08 | FLGT | 18.83 | 0.12 | 0.33 | 4724 |
| 2025-01-09 | FLGT | 18.85 | 0.12 | 0.33 | 4724 |
| 2025-01-10 | FLGT | 18.32 | 0.13 | 0.50 | 4725 |
| 2025-01-13 | FLGT | 17.92 | 0.13 | 0.04 | 4731 |
| 2025-01-14 | FLGT | 17.12 | 0.12 | 1.77 | 4771 |
| 2025-01-15 | FLGT | 16.9 | 0.13 | 0.25 | 4827 |
| 2025-01-16 | FLGT | 17.49 | 0.13 | 1.34 | 4806 |
| 2025-01-17 | FLGT | 17.09 | 0.14 | 0.74 | 4945 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | FLGT | 18.77 | -231.8 | 66.7 | -0.16 |
| 2024-12-20 | FLGT | 18.36 | -231.8 | 68.1 | -0.16 |
| 2024-12-23 | FLGT | 18.59 | -231.8 | 66.1 | -0.16 |
| 2024-12-24 | FLGT | 18.51 | -231.8 | 67.1 | -0.16 |
| 2024-12-26 | FLGT | 18.68 | -231.8 | 66.2 | -0.16 |
| 2024-12-27 | FLGT | 18.36 | -231.8 | 67.8 | -0.16 |
| 2024-12-30 | FLGT | 18.42 | -231.8 | 66.7 | -0.16 |
| 2024-12-31 | FLGT | 18.47 | -231.8 | 66.7 | -0.16 |
| 2025-01-02 | FLGT | 18.40 | -231.8 | 67.1 | -0.16 |
| 2025-01-03 | FLGT | 18.74 | -231.8 | 65.8 | -0.16 |
| 2025-01-06 | FLGT | 18.80 | -231.8 | 66.7 | -0.16 |
| 2025-01-07 | FLGT | 18.95 | -231.8 | 66.3 | -0.16 |
| 2025-01-08 | FLGT | 18.85 | -231.8 | 67.1 | -0.16 |
| 2025-01-09 | FLGT | 18.85 | -231.8 | 66.8 | -0.16 |
| 2025-01-10 | FLGT | 18.32 | -231.8 | 68.5 | -0.16 |
| 2025-01-13 | FLGT | 17.95 | -231.8 | 68.0 | -0.16 |
| 2025-01-14 | FLGT | 17.12 | -231.8 | 69.6 | -0.16 |
| 2025-01-15 | FLGT | 16.90 | -231.8 | 67.7 | -0.16 |
| 2025-01-16 | FLGT | 17.50 | -231.8 | 64.6 | -0.16 |
| 2025-01-17 | FLGT | 17.10 | -231.8 | 68.2 | -0.16 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | FLGT | -0.14 | 5.67 | 3.74 |
| 2024-12-20 | FLGT | -0.14 | 5.67 | 3.74 |
| 2024-12-23 | FLGT | -0.15 | 5.65 | 3.74 |
| 2024-12-24 | FLGT | -0.15 | 5.65 | 3.74 |
| 2024-12-26 | FLGT | -0.15 | 5.65 | 4.10 |
| 2024-12-27 | FLGT | -0.14 | 5.65 | 4.10 |
| 2024-12-30 | FLGT | -0.15 | 5.68 | 4.10 |
| 2024-12-31 | FLGT | -0.15 | 5.68 | 4.10 |
| 2025-01-02 | FLGT | -0.14 | 5.68 | 4.10 |
| 2025-01-03 | FLGT | -0.14 | 5.68 | 4.10 |
| 2025-01-06 | FLGT | -0.14 | 5.68 | 4.10 |
| 2025-01-07 | FLGT | -0.14 | 5.68 | 4.10 |
| 2025-01-08 | FLGT | -0.14 | 5.68 | 4.10 |
| 2025-01-09 | FLGT | -0.14 | 5.68 | 4.10 |
| 2025-01-10 | FLGT | -0.14 | 5.68 | 4.10 |
| 2025-01-13 | FLGT | -0.14 | 6.21 | 4.85 |
| 2025-01-14 | FLGT | -0.14 | 6.21 | 4.85 |
| 2025-01-15 | FLGT | -0.14 | 6.21 | 4.85 |
| 2025-01-16 | FLGT | -0.14 | 6.21 | 4.85 |
| 2025-01-17 | FLGT | -0.14 | 6.21 | 4.85 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.05
Avg. EPS Est. Current Quarter
-0.37
Avg. EPS Est. Next Quarter
-0.13
Insider Transactions
-0.14
Institutional Transactions
6.21
Beta
1.41
Average Sales Estimate Current Quarter
75
Average Sales Estimate Next Quarter
73
Fair Value
Quality Score
37
Growth Score
38
Sentiment Score
4
Actual DrawDown %
91
Max Drawdown 5-Year %
-90.9
Target Price
26.33
P/E
Forward P/E
PEG
P/S
1.88
P/B
0.46
P/Free Cash Flow
EPS
-5.53
Average EPS Est. Cur. Y
-0.16
EPS Next Y. (Est.)
-0.46
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-59.39
Relative Volume
0.68
Return on Equity vs Sector %
-33.6
Return on Equity vs Industry %
-24.8
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
0.23
EBIT Estimation
68.2
Fulgent Genetics, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 1184
Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.
stock quote shares FLGT – Fulgent Genetics, Inc. Stock Price stock today
news today FLGT – Fulgent Genetics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FLGT – Fulgent Genetics, Inc. yahoo finance google finance
stock history FLGT – Fulgent Genetics, Inc. invest stock market
stock prices FLGT premarket after hours
ticker FLGT fair value insiders trading